Evidence map›Paper›PMID 21242781›Full record

ArticleCornea2011

Novel CHST6 gene mutations in 2 unrelated cases of macular corneal dystrophy.

Dhara A Patel, George J Harocopos, Shu-Hong Chang, Smita C Vora, Anthony J Lubniewski, Andrew Jw Huang

Open access · greenAbstract readCase Reports
In one paragraph

Article in Cornea, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact, top 82% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Novel compound heterozygous mutations in theAnnals of translational medicine · 2021
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Dhara A PatelDepartment of Ophthalmology and Visual Sciences, Washington University School of Medicine, St Louis, MO 63110, USA.
George J Harocopos
Shu-Hong Chang
Smita C Vora
Anthony J Lubniewski
Andrew Jw Huang
Washington University in St. Louis · US

Funding

WASHINGTON UNIVERSITY CENTER VISION RESEARCHP30EY002687 · NEI · WASHINGTON UNIVERSITY · PI Philip Andrew Ruzycki · 1985 to 2026
$18.4M
Research Training Program in the Vision SciencesT32EY013360 · NEI · WASHINGTON UNIVERSITY · PI SHIMING CHEN, Daniel Kerschensteiner · 2000 to 2026
$5.6M
ABNORMAL BIGH3 AGGREGATIONS IN CORNEAL DYSTROPHIESR01EY017609 · NEI · WASHINGTON UNIVERSITY · PI HUANG, ANDREW J.W. · 2008 to 2011
$1.3M
NEI NIH HHS 5-T32-EY13360-09NEI NIH HHS P30 EY002687NEI NIH HHS P30 EY02687NEI NIH HHS R01 EY017609NEI NIH HHS R01EY017609NEI NIH HHS T32 EY013360
6 · The paper itself

Abstract

purposeTo investigate the possible mutations in the carbohydrate sulfotransferase 6 (CHST6) gene of 2 unrelated cases of macular corneal dystrophy (MCD) and to report atypical stromal deposits in one of them.

methodsCorneal tissues were stained with antisulfated keratan sulfate (KS), antitransforming growth factor beta 1-induced protein (TGFBIp), thioflavin-T, alcian blue, and Masson trichrome. Sequencing was performed to identify potential mutations in the CHST6 gene and the fourth and twelfth exons of the TGFBI gene.

resultsAlcian blue staining revealed the presence of multiple subepithelial and intrastromal mucopolysaccharide deposits, confirming the diagnosis of MCD in both cases. Immunofluorescence staining in case 1 revealed the presence of sulfated KS only in the keratocytes and select endothelial cells, consistent with MCD type IA. Preferential expression of sulfated KS was observed in keratocytes and extracellular stromal matrix in case 2, consistent with MCD type II. Atypical subepithelial and superficial stromal deposits were observed in case 1, which stained positively with alcian blue, eosin, Masson trichrome, and thioflavin-T indicating the presence of hyaline and amyloid materials. CHST6 gene sequencing revealed 2 heterozygous mutations in case 1 (a p.Arg211Gln and a novel mutation of p.Arg177Gly) and a novel homozygous mutation of p.Pro186Arg in case 2. No mutations were found in exons 4 or 12 of the TGFBI gene in case 1.

conclusionsSecondary hyalinosis and amyloidosis occur in a case of MCD type IA with a novel p.Arg177Gly mutation in CHST6. A novel p.Pro186Arg mutation in CHST6 is associated with MCD type II in an African American.

Indexed as

Point MutationAdultAlcian BlueAmyloidogenic ProteinsAmyloidosisbetaIG-H3 ProteinCarbohydrate SulfotransferasesColoring AgentsCorneal Dystrophies, HereditaryCorneal StromaDNA Mutational AnalysisExtracellular Matrix ProteinsFemaleHumansKeratoplasty, PenetratingMaleAlcian BlueAmyloidogenic ProteinsbetaIG-H3 ProteinCarbohydrate SulfotransferasesColoring AgentsExtracellular Matrix ProteinsSulfotransferasesTransforming Growth Factor beta

Identifiers

PMID21242781
PMCPMC3092828
OpenAlexW2078754430

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.